Meet Syngene Leadership
at BIO International Convention,

Syngene is a fully integrated partner for biopharma innovation, offering end‑to‑end services across drug discovery, development, clinical research, and manufacturing for both small and large molecules. Our capabilities span traditional and niche modalities, including ADCs, peptides, and oligonucleotides, enabling seamless progression from molecule to market. 

Strengthened by expanded biologics capabilities in the U.S. and recognized by TIME as one of the world’s most sustainable companies, Syngene brings together scientific excellence and a deep commitment to the planet. Through innovative, flexible, and efficient development and manufacturing approaches, we help our partners scale rapidly, accelerate go‑to‑market timelines, and expand patient access worldwide.